Sang Cheol Lee

Materials Science · Physical Sciences

22h-index1.9kcitations169works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Crystallization and Solubility Studies(32), X-ray Diffraction in Crystallography(31), Polymer crystallization and properties(18), biodegradable polymer synthesis and properties(18), Polymer Nanocomposites and Properties(14)

Publications169 total

Comparative Analysis of Road Traffic Factors Affecting Autonomous vs. Manual Driving Safety
The Journal of The Korea Institute of Intelligent Transport Systems·2025
Single‑center, retrospective, evaluator‑blinded, pilot and pivotal clinical trials: Assessing the mirCaP Kit (hsv2‑miR‑H9/hsa‑miR‑3659) as a diagnostic marker for prostate cancer in patients with PSA levels in the gray zone
Oncology Letters·2024Open Access
Retrospective, Evaluator-Blinded, Pilot and Pivotal Clinical Trials: Assessing the mirCaP Kit (hsv2-miR-H9/has-miR-3659) as a Diagnostic Marker for Prostate Cancer in Patients with PSA Gray Zone Levels
Research Square (Research Square)·2024Open Access
Malnutrition risk, nutritional knowledge, and dietary intake in chronic kidney disease patients on hemodialysis: comparison according to coexisting diabetes
Journal of Nutrition and Health·2024Open Access
Nucleoredoxin gene SINRX1 negatively regulates tomato immunity by activating SA signaling pathway
Plant Physiology and Biochemistry·2023· 21 cited
Figure S2 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Data from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S1 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S6 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S3 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S6 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S4 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S1 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S2 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S3 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S5 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S4 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Figure S5 from Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
2023Open Access
Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data
Cancer Research and Treatment·2021· 11 citedOpen Access
Effect of pre-operative internal obturator muscle mass index in MRI on biochemical recurrence of prostate cancer patients after radical prostatectomy: a multi-center study
BMC Urology·2021· 2 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Young Gyu Jeong(21), Won Ho Jo(14), Chang Wook Jeong(7), Sung Kyu Hong(7), Seong Jin Jeong(6), In Gyu Hwang(5), Seok‐Soo Byun(5), Jeong Keun Lee(4), Byeong-Bae Park(4), Seok Joong Yun(4), Byung Ki Lee(3), Kihyun Kım(3), Jinwoo Jeong(3), Jeong Hyun Kim(3), Pancě Naumov(3), Ihn Hee Chung(3), Wun‐Jae Kim(3), Hyeon June Kim(2), Jong Jin Oh(2), Cheol Yong Yoon(2)